AM251
To Order Contact us: lieven@wlsolutions.be
AM251 |
||
| B1427-5 | 5 mg | EUR 40 |
|
Description: GPCR/G protein|Cannabinoid Receptor |
||
AM251 |
||
| B1427-50 | 50 mg | EUR 200 |
|
Description: GPCR/G protein|Cannabinoid Receptor |
||
AM251 |
||
| B1427-S | Evaluation Sample | EUR 24 |
|
Description: GPCR/G protein|Cannabinoid Receptor |
||
AM251 |
||
| abx282447-100g | 100 µg | Ask for price |
AM251 |
||
| abx282447-20g | 20 µg | EUR 143.75 |
AM251 |
||
| abx282447-50g | 50 µg | EUR 387.5 |
AM251 |
||
| MBS132777-100mg | 100mg | EUR 1065 |
AM251 |
||
| MBS132777-500mg | 500mg | EUR 2775 |
AM251 |
||
| HY-15443 | 100mg | EUR 340.91 |
|
Description: AM251 is a selective cannabinoid 1 (CB1) receptor antagonist with an IC50 of 8 nM. AM251 also acts as a potent GPR55 agonist with an EC50 of 39 nM[1][2][3]. |
||
AM251 |
||
| MBS575397-10mg | 10mg | EUR 160 |
AM251 |
||
| MBS575397-50mg | 50mg | EUR 280 |
AM251 |
||
| MBS575397-5mg | 5mg | EUR 145 |
AM251 |
||
| MBS575397-5x50mg | 5x50mg | EUR 1120 |
AM251 |
||
| MBS384174-100mg | 100mg | EUR 520 |
AM251 |
||
| MBS384174-10mg | 10mg | EUR 155 |
AM251 |
||
| MBS384174-1mLinDMSO | 1mL(inDMSO) | EUR 195 |
AM251 |
||
| MBS384174-25mg | 25mg | EUR 220 |
AM251 |
||
| MBS384174-50mg | 50mg | EUR 330 |
AM251 |
||
| MBS3602824-100mg | 100mg | EUR 510 |
AM251 |
||
| MBS3602824-10mg | 10mg | EUR 220 |
AM251 |
||
| MBS3602824-25mg | 25mg | EUR 285 |
AM251 |
||
| MBS3602824-50mg | 50mg | EUR 385 |
AM251 |
||
| MBS3602824-5mg | 5mg | EUR 200 |
AM251 |
||
| T1915-10mg | 10mg | Ask for price |
|
Description: AM251 |
||
AM251 |
||
| T1915-1g | 1g | Ask for price |
|
Description: AM251 |
||
AM251 |
||
| T1915-1mg | 1mg | Ask for price |
|
Description: AM251 |
||
AM251 |
||
| T1915-50mg | 50mg | Ask for price |
|
Description: AM251 |
||
AM251 |
||
| T1915-5mg | 5mg | Ask for price |
|
Description: AM251 |
||
SARS-CoV-2 Spike Antibody (AM015553)(Clone AM015553 (553-15)) |
||
| MBS389539-01mg | 0.1mg | EUR 595 |
SARS-CoV-2 Spike Antibody (AM015553)(Clone AM015553 (553-15)) |
||
| MBS389539-5x01mg | 5x0.1mg | EUR 2600 |
SARS-CoV-2 Spike Antibody (AM002413)(Clone AM002413 (413-2)) |
||
| MBS389540-01mg | 0.1mg | EUR 595 |
SARS-CoV-2 Spike Antibody (AM002413)(Clone AM002413 (413-2)) |
||
| MBS389540-5x01mg | 5x0.1mg | EUR 2600 |
SARS-CoV-2 Spike Antibody (AM020553)(Clone AM020553 (553-20)) |
||
| MBS389541-01mg | 0.1mg | EUR 595 |
SARS-CoV-2 Spike Antibody (AM020553)(Clone AM020553 (553-20)) |
||
| MBS389541-5x01mg | 5x0.1mg | EUR 2600 |
SARS-CoV-2 Spike Antibody (AM005505)(Clone AM005505 (505-5)) |
||
| MBS389542-01mg | 0.1mg | EUR 595 |
SARS-CoV-2 Spike Antibody (AM005505)(Clone AM005505 (505-5)) |
||
| MBS389542-5x01mg | 5x0.1mg | EUR 2600 |
SARS-CoV-2 Spike Antibody (AM017553)(Clone AM017553 (553-17)) |
||
| MBS389544-01mg | 0.1mg | EUR 595 |
SARS-CoV-2 Spike Antibody (AM017553)(Clone AM017553 (553-17)) |
||
| MBS389544-5x01mg | 5x0.1mg | EUR 2600 |
SARS-CoV-2 Spike Antibody (AM018553)(Clone AM018553 (553-18)) |
||
| MBS389545-01mg | 0.1mg | EUR 595 |
SARS-CoV-2 Spike Antibody (AM018553)(Clone AM018553 (553-18)) |
||
| MBS389545-5x01mg | 5x0.1mg | EUR 2600 |
SARS-CoV-2 Spike Antibody (AM027553)(Clone AM027553 (553-27)) |
||
| MBS389546-01mg | 0.1mg | EUR 595 |
SARS-CoV-2 Spike Antibody (AM027553)(Clone AM027553 (553-27)) |
||
| MBS389546-5x01mg | 5x0.1mg | EUR 2600 |
SARS-CoV-2 Spike Antibody (AM063553)(Clone AM063553 (553-63)) |
||
| MBS389547-01mg | 0.1mg | EUR 595 |
SARS-CoV-2 Spike Antibody (AM063553)(Clone AM063553 (553-63)) |
||
| MBS389547-5x01mg | 5x0.1mg | EUR 2600 |
SARS-CoV-2 Spike IgG/IgM Antibody (AM043105)(Clone AM043105 (105-43)) |
||
| MBS389543-01mg | 0.1mg | EUR 595 |
SARS-CoV-2 Spike IgG/IgM Antibody (AM043105)(Clone AM043105 (105-43)) |
||
| MBS389543-5x01mg | 5x0.1mg | EUR 2600 |
AbFlex SARS-CoV-2 Spike Antibody (rAb)(AM002414)(Clone AM002414 (414-2)) |
||
| MBS389532-001mg | 0.01mg | EUR 165 |
AbFlex SARS-CoV-2 Spike Antibody (rAb)(AM002414)(Clone AM002414 (414-2)) |
||
| MBS389532-01mg | 0.1mg | EUR 465 |
AbFlex SARS-CoV-2 Spike Antibody (rAb)(AM002414)(Clone AM002414 (414-2)) |
||
| MBS389532-5x01mg | 5x0.1mg | EUR 2025 |
AbFlex SARS-CoV-2 Spike Antibody (rAb)(AM009105)(Clone AM009105 (105-9)) |
||
| MBS389533-001mg | 0.01mg | EUR 165 |
AbFlex SARS-CoV-2 Spike Antibody (rAb)(AM009105)(Clone AM009105 (105-9)) |
||
| MBS389533-01mg | 0.1mg | EUR 465 |
AbFlex SARS-CoV-2 Spike Antibody (rAb)(AM009105)(Clone AM009105 (105-9)) |
||
| MBS389533-5x01mg | 5x0.1mg | EUR 2025 |
AbFlex SARS-CoV-2 Spike Antibody (rAb)(AM043105)(Clone AM043105 (105-43)) |
||
| MBS389534-001mg | 0.01mg | EUR 165 |
AbFlex SARS-CoV-2 Spike Antibody (rAb)(AM043105)(Clone AM043105 (105-43)) |
||
| MBS389534-01mg | 0.1mg | EUR 465 |
AbFlex SARS-CoV-2 Spike Antibody (rAb)(AM043105)(Clone AM043105 (105-43)) |
||
| MBS389534-5x01mg | 5x0.1mg | EUR 2025 |
AbFlex SARS-CoV-2 Spike Antibody (rAb)(AM038105)(Clone AM038105 (105-38)) |
||
| MBS389536-001mg | 0.01mg | EUR 165 |
AbFlex SARS-CoV-2 Spike Antibody (rAb)(AM038105)(Clone AM038105 (105-38)) |
||
| MBS389536-01mg | 0.1mg | EUR 465 |
AbFlex SARS-CoV-2 Spike Antibody (rAb)(AM038105)(Clone AM038105 (105-38)) |
||
| MBS389536-5x01mg | 5x0.1mg | EUR 2025 |
AbFlex SARS-CoV-2 Spike Antibody (rAb)(AM004414)(Clone AM004414 (414-4)) |
||
| MBS389537-001mg | 0.01mg | EUR 165 |
AbFlex SARS-CoV-2 Spike Antibody (rAb)(AM004414)(Clone AM004414 (414-4)) |
||
| MBS389537-01mg | 0.1mg | EUR 465 |
AbFlex SARS-CoV-2 Spike Antibody (rAb)(AM004414)(Clone AM004414 (414-4)) |
||
| MBS389537-5x01mg | 5x0.1mg | EUR 2025 |
AbFlex SARS-CoV-2 Spike Antibody (rAb)(AM001414)(Clone AM001414 (414-1)) |
||
| MBS389538-001mg | 0.01mg | EUR 165 |
AbFlex SARS-CoV-2 Spike Antibody (rAb)(AM001414)(Clone AM001414 (414-1)) |
||
| MBS389538-01mg | 0.1mg | EUR 465 |
AbFlex SARS-CoV-2 Spike Antibody (rAb)(AM001414)(Clone AM001414 (414-1)) |
||
| MBS389538-5x01mg | 5x0.1mg | EUR 2025 |
AM-92016 HCl |
||
| 555585 | 25.0mg | EUR 250 |
SARS-CoV-2 Spike Antibody (AM009105) |
||
| MBS389523-01mg | 0.1mg | EUR 595 |
SARS-CoV-2 Spike Antibody (AM009105) |
||
| MBS389523-5x01mg | 5x0.1mg | EUR 2600 |
SARS-CoV-2 Spike Antibody (AM038105) |
||
| MBS389524-01mg | 0.1mg | EUR 595 |
SARS-CoV-2 Spike Antibody (AM038105) |
||
| MBS389524-5x01mg | 5x0.1mg | EUR 2600 |
SARS-CoV-2 Spike Antibody (AM043105) |
||
| MBS389525-01mg | 0.1mg | EUR 595 |
SARS-CoV-2 Spike Antibody (AM043105) |
||
| MBS389525-5x01mg | 5x0.1mg | EUR 2600 |
SARS-CoV-2 Spike Antibody (AM004414) |
||
| MBS389526-01mg | 0.1mg | EUR 595 |
SARS-CoV-2 Spike Antibody (AM004414) |
||
| MBS389526-5x01mg | 5x0.1mg | EUR 2600 |
SARS-CoV-2 Spike Antibody (AM005415) |
||
| MBS389527-01mg | 0.1mg | EUR 595 |
SARS-CoV-2 Spike Antibody (AM005415) |
||
| MBS389527-5x01mg | 5x0.1mg | EUR 2600 |
SARS-CoV-2 Spike Antibody (AM002414) |
||
| MBS389528-01mg | 0.1mg | EUR 595 |
SARS-CoV-2 Spike Antibody (AM002414) |
||
| MBS389528-5x01mg | 5x0.1mg | EUR 2600 |
SARS-CoV-2 Spike Antibody (AM006415) |
||
| MBS389529-01mg | 0.1mg | EUR 595 |
SARS-CoV-2 Spike Antibody (AM006415) |
||
| MBS389529-5x01mg | 5x0.1mg | EUR 2600 |
SARS-CoV-2 Spike Antibody (AM032414) |
||
| MBS389530-01mg | 0.1mg | EUR 595 |
SARS-CoV-2 Spike Antibody (AM032414) |
||
| MBS389530-5x01mg | 5x0.1mg | EUR 2600 |
SARS-CoV-2 Spike Antibody (AM001414) |
||
| MBS389531-01mg | 0.1mg | EUR 595 |
SARS-CoV-2 Spike Antibody (AM001414) |
||
| MBS389531-5x01mg | 5x0.1mg | EUR 2600 |
AM2232 |
||
| A186910 | 25mg | EUR 3000 |
|
Description: 335161-19-8 |
||
AM-4668 |
||
| 522369 | 10.0mg | EUR 385 |
AM-0902 |
||
| 522645 | 25.0mg | EUR 250 |
AM-1235 |
||
| 524171 | 1.0mg | EUR 225 |
AM-1241 |
||
| 524172 | 1.0mg | EUR 205 |
AM-1248 |
||
| 524173 | 5.0mg | EUR 240 |
AM-2232 |
||
| 524182 | 5.0mg | EUR 225 |
AM-2233 |
||
| 524183 | 1.0mg | EUR 205 |
AM4113 |
||
| 525320 | 50.0mg | EUR 750 |
AM-2394 |
||
| 526657 | 10.0mg | Ask for price |
AM-1172 |
||
| 573116 | 5.0mg | EUR 250 |
AM-3102 |
||
| 573764 | 5.0mg | EUR 215 |
(R)-AM1241 |
||
| 573768 | 1.0mg | EUR 230 |
(S)-AM1241 |
||
| 573769 | 1.0mg | EUR 230 |
AM-2201 |
||
| A575830 | 10mg | EUR 218 |
|
Description: 335161-24-5 |
||
AM-1220 |
||
| A575835 | 250mg | EUR 1200 |
|
Description: 137642-54-7 |
||
AM-2233 |
||
| A575850 | 10mg | EUR 184 |
|
Description: 444912-75-8 |
||
AM1241 |
||
| A5827-10 | 10 mg | EUR 72 |
|
Description: GPCR/G protein|Cannabinoid Receptor |
||
AM1241 |
||
| A5827-25 | 25 mg | EUR 160 |
|
Description: GPCR/G protein|Cannabinoid Receptor |
||
AM1241 |
||
| A5827-5 | 5 mg | EUR 40 |
|
Description: GPCR/G protein|Cannabinoid Receptor |
||
AM1241 |
||
| A5827-5.1 | 10 mM (in 1mL DMSO) | EUR 88 |
|
Description: GPCR/G protein|Cannabinoid Receptor |
||
AM6545 |
||
| C4711-10 | 10 mg | EUR 285.6 |
|
Description: GPCR/G protein|Cannabinoid Receptor |
||
AM6545 |
||
| C4711-25 | 25 mg | EUR 648.8 |
|
Description: GPCR/G protein|Cannabinoid Receptor |
||
AM6545 |
||
| C4711-5 | 5 mg | EUR 193.6 |
|
Description: GPCR/G protein|Cannabinoid Receptor |
||
AM4113 |
||
| C3493-10 | 10 mg | EUR 136.8 |
|
Description: GPCR/G protein|Cannabinoid Receptor |
||
AM4113 |
||
| C3493-25 | 25 mg | EUR 510.4 |
|
Description: GPCR/G protein|Cannabinoid Receptor |
||
AM4113 |
||
| C3493-5 | 5 mg | EUR 82.4 |
|
Description: GPCR/G protein|Cannabinoid Receptor |
||
AM-2394 |
||
| MBS131377-100mg | 100mg | EUR 1495 |
AM2233 |
||
| MBS132046-100mg | 100mg | EUR 1065 |
AM2233 |
||
| MBS132046-500mg | 500mg | EUR 2775 |
AM-0902 |
||
| MBS131898-INQUIRE | INQUIRE | Ask for price |
AM-2394 |
||
| HY-100221 | 10mM/1mL | EUR 454.55 |
|
Description: AM-2394 is a structurally distinct glucokinase activator (GKA). AM-2394 activates glucokinase (GK) with an EC50 of 60 nM. |
||
AM-2099 |
||
| HY-100727 | 10mM/1mL | EUR 432.91 |
|
Description: AM-2099 is a potent and selective inhibitor of voltage-gated sodium channel Nav1.7 with an IC50 of 0.16 μM for human Nav1.7. |
||
AM-0902 |
||
| HY-108329 | 100mg | EUR 571.44 |
|
Description: AM-0902 is a potent, selective transient receptor potential A1 (TRPA1) antagonist with IC50s of 71 and 131 nM for rTRPA1 and hTRPA1, respectively. |
||
AM6545 |
||
| HY-110206 | 1 mg | EUR 111.47 |
|
Description: AM6545 is a peripherally active, cannabinoid receptor antagonist with limited brain penetration. AM6545 binds to CB1 and CB2 receptors with Kis of 1.7 nM and 523 nM, respectively. AM6545 is a neutral antagonist. AM6545 can be used for the research of obesity and its complications[1]. |
||
AM9405 |
||
| HY-112707 | Get quote | Ask for price |
|
Description: AM9405 is a novel peripherally active cannabinoid type 1 (CB1) and serotonin type 3 receptor agonist. AM9405 inhibits twitch contraction of the ileum and the colon with IC50s of 45.71 and 0.076 nM, respectively. |
||
AM-9022 |
||
| HY-162110 | 1 mg | EUR 1352.84 |
|
Description: AM-9022 is an orally active, potent, selective KIF18A inhibitor that can be used for research on cancer[1]. |
||
AM-5262 |
||
| HY-16619 | Get quote | Ask for price |
|
Description: AM-5262 is a GPR40 full agonist with an EC50 value of 0.081 μM. AM-5262 can be used for the research of type II diabetes[1]. |
||
AM-8553 |
||
| HY-18052 | Get quote | Ask for price |
|
Description: AM-8553 is a MDM2/p53 inhibitor (KD: 0.4 nM for MDM2). AM-8553 has anti-tumor activity[1] |
||
AM-4668 |
||
| HY-12585 | 5mg | EUR 909.11 |
|
Description: AM-4668 is a GPR40 agonist for type 2 diabetes. EC50s of 3.6 nM and 36 nM for GPR40 in A9 cells (GPR40 IP3 assay) and CHO cells (GPR40 aequorin assay), respectively[1]. |
||
AM-8735 |
||
| HY-12734 | Get quote | Ask for price |
|
Description: AM-8735 is a potent and selective MDM2 inhibitor with an IC50 of 25 nM. |
||
AM-6494 |
||
| HY-128774 | Get quote | Ask for price |
|
Description: AM-6494 is a potent and orally active BACE1 (efficacious β-site amyloid precursor protein cleaving enzyme 1) inhibitor (IC50=0.4 nM) with in vivo selectivity over BACE2 (IC50=18.6 nM)[1]. AM-6494 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups. |
||
AM-7209 |
||
| HY-12941 | Get quote | Ask for price |
|
Description: AM-7209 is a potent and selective MDM2-p53 interaction inhibitor with a Kd of 38 pM. AM-7209 inhibits the MDM2 amplified SJSA-1 osteosarcoma cell line with an IC50 of 1.6 nM. AM-7209 shows antitumor activities[1]. |
||
AM3102 |
||
| HY-129683 | 5mg | EUR 111.47 |
|
Description: AM3102 is an oleoylethanolamide (OEA) analog. AM3102 is an endogenous high-affinity PPAR-alpha agonist. AM3102 resists enzymatic hydrolysis, activates PPAR-alpha with high potency in vitro, and persistently reduces feeding when administered in vivo either parenterally or orally[1]. |
||
AM-1638 |
||
| HY-13467 | 5mg | EUR 1515.18 |
|
Description: AM-1638 is a potent and orally bioavailable GPR40/FFA1 full agonist with an EC50 of 0.16 μM. |
||
AM-6538 |
||
| HY-120423 | 10 mg | EUR 2380.99 |
|
Description: AM6538 is a long-acting, high affinity and pseudo-irreversible cannabinoid (CB) antagonist. AM6538 is a structural analog of rimonabant. AM6538 can be effectively used to evaluate the apparent efficacy of cannabinoid full and partial agonists. AM6538 may be useful in future studies that require temporary reductions in cannabinoid receptor availability[1]. AM-6538 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups. |
||
AM8936 |
||
| HY-144827 | Get quote | Ask for price |
|
Description: AM8936 acts as a balanced and potent cannabinoid receptor type-1 (CB1) agonist in functional assays (EC50s of 8.6 and 1.4 nM for rCB1 and hCB1, respectively). AM8936 exhibits high affinity for rat CB1 (rCB1) with Ki of 0.55 nM. AM8936 is a potent and efficacious CB1 agonist in vivo. AM8936 can be used for the research of CNS and metabolic disorders, pain, glaucoma, etc[1]. |
||
AM-5308 |
||
| HY-144894 | 10 mg | EUR 2359.34 |
|
Description: AM-5308 is a potent kinesin KIF18A inhibitor (WO2021211549A1, C13)[1]. |
||
AM-1488 |
||
| HY-147367 | Get quote | Ask for price |
|
Description: AM-1488 is a potent, orally active glycine receptor (GlyR) potentiator (hGlyRα3 EC50=0.45 μM)[1][2]. |
||
AM-8123 |
||
| HY-139486 | 100mg | Ask for price |
|
Description: AM-8123 is an orally active and potent APJ agonist. AM-8123 inhibits Forskolin-stimulated cAMP production and promotes Gα protein activation. AM-8123 can be used for the research of cardiovascular disease[1]. |
||
AM-2394 |
||
| MBS578348-100mg | 100mg | EUR 635 |
AM-2394 |
||
| MBS578348-10mg | 10mg | EUR 195 |
AM-2394 |
||
| MBS578348-2mg | 2mg | EUR 155 |
AM-2394 |
||
| MBS578348-50mg | 50mg | EUR 465 |
AM-2394 |
||
| MBS578348-5mg | 5mg | EUR 175 |
AM-0466 |
||
| MBS5776333-INQUIRE | INQUIRE | Ask for price |
AM-0687 |
||
| MBS5776334-5mg | 5(mg | EUR 915 |
AM-0687 |
||
| MBS5776334-5x5mg | 5x5(mg | EUR 3970 |
AM-1430 |
||
| MBS5776335-INQUIRE | INQUIRE | Ask for price |
AM-5262 |
||
| MBS5776336-5mg | 5(mg | EUR 915 |
AM-5262 |
||
| MBS5776336-5x5mg | 5x5(mg | EUR 3970 |
AM-6761 |
||
| MBS5776337-5mg | 5(mg | EUR 915 |
AM-6761 |
||
| MBS5776337-5x5mg | 5x5(mg | EUR 3970 |
AM7499 |
||
| MBS5776338-5mg | 5(mg | EUR 915 |
AM7499 |
||
| MBS5776338-5x5mg | 5x5(mg | EUR 3970 |
AM-1220 |
||
| MBS5779559-5mg | 5(mg | EUR 915 |
AM-1220 |
||
| MBS5779559-5x5mg | 5x5(mg | EUR 3970 |
AM-1235 |
||
| MBS5779560-5mg | 5(mg | EUR 915 |
AM-1235 |
||
| MBS5779560-5x5mg | 5x5(mg | EUR 3970 |
AM-1714 |
||
| MBS5779562-5mg | 5(mg | EUR 915 |
AM-1714 |
||
| MBS5779562-5x5mg | 5x5(mg | EUR 3970 |
AM-2159 |
||
| MBS5779564-5mg | 5(mg | EUR 915 |
AM-2159 |
||
| MBS5779564-5x5mg | 5x5(mg | EUR 3970 |
AM-3102 |
||
| MBS5779565-10mg | 10mg | EUR 365 |
AM-3102 |
||
| MBS5779565-50mg | 50(mg | EUR 665 |
AM-3102 |
||
| MBS5779565-5mg | 5(mg | EUR 915 |
AM-3102 |
||
| MBS5779565-5x50mg | 5x50mg | EUR 2855 |
AM-6826 |
||
| MBS5779568-INQUIRE | INQUIRE | Ask for price |
AM-6538 |
||
| MBS5785293-10mg | 10mg | EUR 630 |
AM-6538 |
||
| MBS5785293-25mg | 25mg | EUR 1605 |
AM-6538 |
||
| MBS5785293-5mg | 5(mg | EUR 435 |
AM-6538 |
||
| MBS5785293-5x25mg | 5x25(mg | EUR 5160 |
AM-8553 |
||
| MBS5773479-5mg | 5mg | EUR 915 |
AM-8553 |
||
| MBS5773479-5x5mg | 5x5mg | EUR 3970 |
AM-0902 |
||
| MBS5758326-100mg | 100mg | EUR 750 |
AM-0902 |
||
| MBS5758326-10mg | 10mg | EUR 185 |
AM-0902 |
||
| MBS5758326-50mg | 50mg | EUR 450 |
AM-0902 |
||
| MBS5758326-5mg | 5mg | EUR 165 |
AM-0902 |
||
| MBS5758326-5x100mg | 5x100mg | EUR 3230 |
AM-2232 |
||
| MBS5756748-10mg | 10mg | EUR 365 |
AM-2232 |
||
| MBS5756748-1mg | 1mg | EUR 180 |
AM-2232 |
||
| MBS5756748-25mg | 25mg | EUR 570 |
AM-2232 |
||
| MBS5756748-2mg | 2mg | EUR 215 |
AM-2232 |
||
| MBS5756748-5mg | 5mg | EUR 255 |
AM-1638 |
||
| MBS5754502-100mg | 100mg | EUR 2580 |
AM-1638 |
||
| MBS5754502-50mg | 50mg | EUR 1905 |
AM-1638 |
||
| MBS5754502-5x100mg | 5x100mg | EUR 11450 |
AM-2099 |
||
| MBS5754503-200mg | 200mg | EUR 1150 |
AM-2099 |
||
| MBS5754503-5x200mg | 5x200mg | EUR 5025 |
AM-4668 |
||
| MBS5754504-50mg | 50mg | EUR 975 |
AM-4668 |
||
| MBS5754504-5x50mg | 5x50mg | EUR 4235 |
AM6545 |
||
| MBS5757061-5mg | 5mg | EUR 915 |